| 摘要 |
FIELD: medicine. ^ SUBSTANCE: invention is referred to pharmaceutical industry, namely - to the extraction for production of composition for prevention, management or treatment of a neurologic disease, condition, dysfunction or disorder. Use of extraction of microalgae Aphanizomenom Flos Aquae Aquae Ralfs ex Born. & Flax. Var. flos algae (AFA Klamath algae) for production of composition for prevention, management or treatment of a neurologic disease, condition, dysfunction or disorder chosen from: Alzheimer disease, Parkinson disease, multiple sclerosis, Attention deficit hyperactivity disorder (ADHD), autism, depression, memory deficiency and affective disorders where the extraction is produced using different stages. ^ EFFECT: prevention, management or treatment of a neurologic disease, condition, dysfunction or disorder. ^ 3 cl, 24 dwg, 3 tbl |
